Digital pathology market seen reaching $3.29 billion by 2030

The global digital pathology market is projected to grow from $1.42 billion in 2025 to $3.29 billion by 2030, driven by cancer diagnostics, AI adoption and telepathology. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - The digital pathology market is expanding as hospitals and labs move from glass slides to digital workflows. - Faster diagnosis, remote review and AI-assisted analysis could improve cancer care and pathology throughput. - The market’s growth signals rising demand for tools that support standardized workflows and data sharing.

What happened: - The Business Research Company published a digital pathology market report covering market size, trends and forecasts through 2035. - The report puts the market at $1.42 billion in 2025 and $1.68 billion in 2026. - The report projects the market will reach $3.29 billion by 2030. - The company also made a free sample of the report and the full report available online.

The details: - The report ties 2025-2026 growth to digitization of pathology labs, cancer diagnostics, telepathology, standardized workflows and wider access to digital scanners. - The report forecasts a 2026-2030 compound annual growth rate of 18.3%. - The 2025-2026 period reflects an 18.5% CAGR. - Digital pathology uses slide scanners, software and related services to convert glass slides into high-resolution digital images. - Those images can be accessed, managed and analyzed on computers or mobile devices. - The report cites rising cancer incidence as a major demand driver. - American Cancer Society data from January 2024 showed U.S. cancer cases rising 2.19% to 2,001,140 from 1,958,310 in 2023. - The report also points to broader use of telepathology, AI technologies, computational pathology and drug discovery applications. - The report highlights whole slide imaging, AI-driven image analysis, remote pathology services, cloud integration and workflow automation as emerging trends. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - North America held the largest market share in 2025. - Asia-Pacific ranked second in market size and is expected to grow quickly. - The 2026 report package adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspot infographics and updated trend analysis.

Between the lines: - The market outlook suggests digital pathology is moving from a niche lab upgrade to a core clinical and research infrastructure layer. - AI and interoperability stand out as the next competitive battlegrounds because they can improve both diagnostic speed and cross-system collaboration. - Cancer’s growing burden gives the category a clear near-term use case, which may support continued investment across software, scanners and analytics.

What's next: - The market’s next phase will likely center on broader AI deployment, cloud-based platforms and workflow automation. - Regions outside North America may narrow the gap if telepathology and digital lab adoption accelerate. - The company is offering sales contacts and report access for buyers seeking deeper market intelligence.